Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Robert Deberardine Abbott Laboratories patentsThe following is a sampling of recent Robert Deberardine Abbott Laboratories patent applications (USPTO Patent Application #, Patent Title) sorted by month.
April 2008 - Robert Deberardine Abbott Laboratories patents
20080092646 - Liquid level sensor
20080096232 - Methods for the detection and diagnosis of trypanosoma cruzi infection
20080097094 - Diazabicyclic central nervous system active agents
20080087283 - Apparatus for and related method of inhibiting lewis acid degradation in a vaporizer
20080089940 - Superporous hydrogels for heavy-duty applications
20080090226 - Novel antigen constructs useful in the detection and differentiation of antibodies to hiv
20080090798 - Heterocyclic substituted aminoazacycles useful as central nervous system agents
20080090994 - Novel antigen constructs useful in the detection and differentiation of antibodies to hiv
20080092250 - Activity-induced pain in animal model of osteoarthritis
20080086124 - Occipito-cervical stabilization system and method
20080081826 - System for effecting weight loss
20080082168 - Surgical scaffold to enhance fibrous tissue response
20080082170 - Apparatus and methods for surgical repair
March 2008 - Robert Deberardine Abbott Laboratories patents
20080076767 - Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
20080076779 - Treatment of myeoproliferative diseases
20080076819 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
20080077025 - Methods for determining how to treat congestive heart failure
20080077139 - Spinal stabilization systems with quick-connect sleeve assemblies for use in surgical procedures
20080070891 - (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
20080070929 - Thiazoline and oxazoline derivatives and their methods of use
20080071062 - Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
20080071151 - Method and apparatus for diagnosing pre-eclampsia
20080064045 - Biomarker fragments for the detection of human bnp
20080064695 - Pyrrole derivatives and their methods of use
20080064699 - Novel compounds as cannabinoid receptor ligands and uses thereof
20080064717 - Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
20080065070 - Spinal plate system for stabilizing a portion of a spine
20080058307 - Novel compounds as cannabinoid receptor ligands
20080058308 - Novel compounds as cannabinoid receptor ligands
20080058335 - Novel compounds as cannabinoid receptor ligands and uses thereof
20080058401 - Compounds that inhibit trpv1 and uses thereof
20080058528 - Synthesis of (2s,5r)-5-ethynyl-1-{n-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile
February 2008 - Robert Deberardine Abbott Laboratories patents
20080051411 - Salts of fenofibric acid and pharmaceutical formulations thereof
20080045539 - Fused bicycloheterocycle substituted azabicyclic alkane derivatives
20080045949 - Method of treating degenerative spinal disorders
20080045957 - Spinal stabilization systems and methods using minimally invasive surgical procedures
20080038265 - Antibodies to erythropoietin receptor and uses thereof
20080039838 - Spinal stabilization systems and methods
20080039942 - Spinal implant
20080031825 - Pharmaceutical compositions comprising effervescent agents and fenofibrate
January 2008 - Robert Deberardine Abbott Laboratories patents
20080024301 - System for tracking vessels in automated laboratory analyzers by radio frequency identification
20080027008 - Antitumorigenic drug combination
20080021081 - Cyclopropyl amine derivatives
20080015182 - Potent parp inhibitors
20080015192 - Inhibitors of polo-like kinases
20080015227 - Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
20080015698 - Spinal disc implant
20080015701 - Spinal implant
20080009864 - Instruments and methods for reduction of vertebral bodies
20080004222 - Antitumorigenic drug combination
20080004448 - (1s,5s)-3-(5.6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
November 2007 - Robert Deberardine Abbott Laboratories patents
20070276402 - Fenestrated bone tap and method
20070269841 - Determination of concentration of fk778 by competitive immunoassay
20070270383 - Prodrugs of hiv protease inhibitors
20070270476 - Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
20070264332 - Sustained release pharmaceutical formulation
20070264334 - Pharmaceutical formulations
20070265249 - Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
20070265302 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
20070265324 - Combination therapy with parp inhibitors
20070259376 - Homocysteine immunoassay
20070259920 - P2x7, receptor antagonists and uses thereof
20070259937 - Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
20070254867 - Heterocyclic kinase inhibitors
20070256149 - Dep2 and its uses in major depressive disorder and other related disorders
20070256148 - Dep2 and its uses in major depressive disorder and other related disorders
October 2007 - Robert Deberardine Abbott Laboratories patents
20070249643 - Solid pharmaceutical dosage form
20070249666 - P2x7 antagonists to treat affective disorders
20070243348 - Closure for container
20070243631 - Determination of concentration of fk778 by competitive immunoassay
20070238753 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
20070238932 - Surgical retractor and retractor assembly
20070231392 - Chemically modified polycation polymer for sirna delivery
20070232612 - Octahydro-pyrrolo[3,4-b]pyrrole derivatives
20070232645 - Anti-viral compounds
20070232686 - Cyanoamidine p2x7 antagonists for the treatment of pain
September 2007 - Robert Deberardine Abbott Laboratories patents
20070219554 - Spinal stabilization systems and methods
20070207122 - Compositons and methods of use of ritonavir for treating hcv
20070207152 - Human bnp immunospecific antibodies
20070208173 - Crystalline hydrates of cefdinir calcium salt
August 2007 - Robert Deberardine Abbott Laboratories patents
20070203143 - Protein kinase inhibitors
20070197558 - Anti-viral compounds
20070187405 - Container for compositions containing cefdinir
20070190142 - Dosage forms for the delivery of drugs of abuse and related methods
20070191437 - Continuous dosing regimen
20070184490 - Neuronal nicotinic receptor ligands and their use
20070185034 - Crystalline form of a drug
20070185199 - Pharmaceutical formulations
20070179136 - 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors
20070179186 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
July 2007 - Robert Deberardine Abbott Laboratories patents
20070166187 - Stabilization of paricalcitol using chlorobutyl or chlorinated butyl stoppers
20070167376 - Hexa-, hepta-, and octapeptides having antiangiogenic activity
20070161123 - Determination of concentration of fk778 by competitive immunoassay
20070161656 - N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-n'-(2-fluoro-5-(trifluoromethyl)phenyl)urea crystalline form 2
20070161657 - Crystalline n-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-n'-(2-fluoro-5-(trifluoromethyl)phenyl)urea hydrobromide
20070161658 - Crystalline n-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-n'-(2-fluoro-5-(trifluoromethyl) phenyl)urea camphorsulfonate
20070161659 - Crystalline n-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-n'-(2-fluoro-5-(trifluoromethyl)phenyl)urea benzenesulfonate
20070161660 - Crystalline n-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-n'-(2-fluoro-5-(trifluoromethyl)phenyl)urea maleate
20070161661 - Crystalline n-(4-(4-ammoniumthieno[2,3-d]pyrimidin-5-yl)phenyl)-n'-(2-fluoro-5-(trifluoromethyl)phenyl)urea ethanesulfonate
20070155758 - Crystalline n-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-n'-(2-fluoro-5-(trifluoromethyl)phenyl)urea ethanolate
June 2007 - Robert Deberardine Abbott Laboratories patents
20070148640 - Methods and kits for decreasing interferences in plasma or serum containing assay samples of specific binding assays
20070148747 - Genes involved in polyketide synthase pathways and uses thereof
20070142855 - Surgical port system with marker ring
20070134286 - Methods for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals
20070135387 - Inhibitors of protein kinases
20070135392 - Apoptosis promoters
20070135401 - Lestaurtinib crystalline form 1, crystalline lestaurimib anhydrate and amorphous lestaurimib
20070135628 - Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemiacetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranate
20070128278 - Pharmaceutical formulations
May 2007 - Robert Deberardine Abbott Laboratories patents
20070123582 - Crystalline form of a drug
20070124837 - Desaturase genes, enzymes encoded thereby, and uses thereof
20070116376 - Image based correction for unwanted light signals in a specific region of interest
20070118218 - Facet joint implant and procedure
20070110280 - Methods for determining coating thickness of a prosthesis
20070111326 - Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
20070105842 - P2x7 receptor antagonists and methods of use
20070105862 - Heat-shock protein binders
20070099295 - Methods for the determination of antibody igg avidity
20070099954 - Prodrugs of compounds that inhibit trpv1 receptor
20070099967 - N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide crystalline form 1
April 2007 - Robert Deberardine Abbott Laboratories patents
20070093459 - Use of vitamin ds or vitamin d analogs to treat cardiovascular disease
20070087396 - Method of tacrolimus extraction and quantification using aqueous detergents
20070088040 - Antibacterial compounds
20070088255 - Method of treating vascular disease at a bifurcated vessel using a coated balloon
20070082410 - Stabilization of cardiac troponin
20070083201 - Apparatus and methods for spinal implant with variable link mechanism
20070077307 - Pharmaceutical compositions
20070078133 - Cyclobutyl amine derivatives
March 2007 - Robert Deberardine Abbott Laboratories patents
20070048384 - Pharmaceutical compositions
20070049584 - Amino-tetrazoles analogues and methods of use
20070049596 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
20070049636 - Pharmaceutical compositions
February 2007 - Robert Deberardine Abbott Laboratories patents
20070043019 - Salt and crystalline forms thereof of a drug
20070043089 - Method of inhibiting angiogenesis
20070034592 - Closure for container for holding biological samples
20070037801 - Novel indoles are cannabinoid receptor ligands
20070032435 - Pharmaceutical formulations
20070032436 - Pharmaceutical formulations
20070027135 - Apoptosis promoters
20070027172 - Crystalline pharmaceutical
20070027523 - Method of treating vascular disease at a bifurcated vessel using coated balloon
January 2007 - Robert Deberardine Abbott Laboratories patents
20070021470 - Crystalline n-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide methanolates
20070021471 - Crystalline n-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide ethanolates
20070012592 - Child-resistant blister package
20070015787 - Apoptosis promoters
20070015804 - Polymorph of a pharmaceutical
20070015911 - Methods for biomarker discovery and diagnostic screening
20070015978 - Method and apparatus for non-invasive measurement of living body characteristics by photoacoustics
20070010019 - Assay testing diagnostic analyzer
20070010557 - Novel amides useful for treating pain
20070004781 - Crystalline n-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide hydrochloride
20070004782 - N-((2z)-2-((4-hydroxyphenyl) amino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide crystalline form 2
December 2006 - Robert Deberardine Abbott Laboratories patents
20060293367 - Amorphous n-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide
20060293368 - Amorphous n-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide hydrochloride
20060293395 - Methods for treating a mammal before, during and after cardiac arrest
20060287289 - Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
20060287290 - Azabicyclic compounds are central nervous system active agents
20060287300 - Anti-infective agents
20060287307 - Antibacterial compounds
20060287356 - Thienopyridones as ampk activators for the treatment of diabetes and obesity
20060287370 - Isoindolinone kinase inhibitors
20060278525 - Biosensor strips and methods of preparing same
20060280790 - Pharmaceutical formulations
20060280791 - Pharmaceutical formulations
20060281773 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
20060281799 - Antagonists of the vanilloid receptor subtype 1 (vr1) and use thereof
20060272387 - Apparatus and method for verifying the volume of liquid dispensed by a liquid-dispensing mechanism
20060275142 - Method for discriminating between operating conditions in medical pump
20060275288 - Glp-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof
20060276484 - Use of selective dopamine d4 receptor agonists for treating sexual dysfunction
20060276490 - Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
20060276505 - Acylhydrazine p2x7 antagonists and uses thereof
November 2006 - Robert Deberardine Abbott Laboratories patents
20060270663 - Substituted 7,8-dihydro-1h-pyrimido[4,5-b][1,4]diazepin-4-amines are novel kinase inhibitors
20060263248 - Reagent and sample handling device for automatic testing system
20060264433 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
20060264476 - Farnesyltransferase inhibitors
20060257957 - Methods to measure immunosuppressive tacrolimus, sirolimus, and cyclosporin a complexes in a blood sample
20060258597 - Antitumorigenic drug combination and dosing schedule
20060258657 - Apoptosis promoters
October 2006 - Robert Deberardine Abbott Laboratories patents
20060239868 - Assembly for carrying and holding slides
20060240070 - Delivery of highly lipophilic agents via medical devices
20060240533 - Assembly for the stabilisation of vertebral bodies of the spine
20060240536 - Fermentation broth extraction of k-252a
20060228411 - Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
20060228452 - Delivery of highly lipophilic agents via medical devices
20060228453 - Delivery of highly lipophilic agents via medical devices
20060229280 - Endothelin antagonists
20060229289 - 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
20060229310 - Antibacterial compounds
20060229351 - 2-substituted-1 h-benzimidazile-4-carboxamides are parp inhibitors
20060229608 - Apparatus and methods for spinal implant with dynamic stabilization system
20060229627 - Variable angle spinal surgery instrument
August 2006 - Robert Deberardine Abbott Laboratories patents
20060171983 - Use of vitamin d receptor activators or vitamin d analogs to treat cardiovascular disease
20060171984 - Device having hydration inhibitor
20060172995 - Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
20060173050 - Inhibitors of c-jun n-terminal kinases
20060173469 - Device and method for suturing of internal puncture sites
July 2006 - Robert Deberardine Abbott Laboratories patents
20060166906 - 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance
20060167476 - Systems, devices and methods for suturing patient tissue
20060167477 - Device and method for performing end-to-side anastomosis
20060160806 - Ureas having antiangiogenic activity
20060153866 - Novel antigen constructs useful in the detection and differentiation of antibodies to hiv
20060154902 - Shortening of hospital stay and improving survival in patients with chronic kidney disease
20060144704 - Analyte test sensor and method of manufacturing the same
20060148843 - Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof
20060148867 - Antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof
20060148871 - Metabolic stabilization of substituted adamantane
20060148906 - Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
20060149070 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
20060149256 - System and method for stabilizing the human spine with a bone plate
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Robert Deberardine Abbott Laboratories in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Robert Deberardine Abbott Laboratories with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
